Efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicentre cohort of patients with suppressed HIV‐1 replication

Objectives We evaluated the efficacy and tolerability of lamivudine + dolutegravir in a cohort of HIV‐1 infected, treatment‐experienced patients with undetectable HIV‐RNA. Methods Time to treatment discontinuation (TD) and virological failure (VF) and their predictors were assessed in a multicenter...

Ausführliche Beschreibung